Methods for rapid multiplexed amplification of target nucleic acids
A fast, multiplexed PCR system is described that can rapidly generate amplified nucleic acid products, for example, a full STR profile, from a target nucleic acid. Such systems include, for example, microfluidic biochips and a custom built thermal cycler, which are also described. The resulting STR profiles can satisfy forensic guidelines for signal strength, inter-loci peak height balance, heterozygous peak height ratio, incomplete non-template nucleotide addition, and stutter.
1. A method for simultaneously amplifying of a plurality of loci in a nucleic acid solution comprising:
providing in single solutions contained in a plurality of reaction chambers located in a biochip, samples having at least ten and up to 250 target nucleic acid loci to be amplified, with at least ten and up to 250 different primer pairs, each primer pair hybridizing to one of the at least ten and up to 250 loci to be amplified, said solution further comprising:
(i) one or more buffers;
(ii) one or more salts;
(iii) a nucleic acid polymerase; and
(iv) nucleotides; and
providing a TCE, comprising a means for heating and cooling, at least one thermosensor, a controller that receives signals from said at least one thermosensor and a power supply, said at least one thermosensor positioned and configured to measure the effective temperature of each of the single solutions in the reaction chambers of the biochip and to provide feedback to the TCE to heat or cool the solution to set or maintain the solution at a desired temperature;
simultaneously amplifying said plurality of loci by using the at least one thermosensor, the controller and the TCE to sequentially thermally cycle the temperature of the nucleic acid solution in each reaction chamber between a denaturing state, an annealing state, and an extension state for a predetermined number of cycles at heating and cooling rates of about 4-150° C./sec, and minimizing the transition times between the extension, denaturation, and annealing states to yield a plurality of amplified loci in each reaction chamber in 97 minutes or less.
2. The method of claim 1 , further comprising:
holding the a plurality of reaction solutions at a final state to provide one or a plurality of amplified nucleic acid products.
3. A method for simultaneously amplifying 5 or more loci in a nucleic acid solution comprising:
providing in single solutions contained in a plurality of reaction chambers located in a biochip, samples having at least five target nucleic acid loci to be amplified, with at least five different primer pairs, each primer pair hybridizing to one of at least five loci, said solution further comprising:
(i) one or more buffers;
(ii) one or more salts;
(iii) a nucleic acid polymerase; and
(iv) nucleotides; and
providing a TCE, comprising a means for heating and cooling, at least one thermosensor, a controller that receives signals from said at least one thermosensor and a power supply, said at least one thermosensor positioned and configured to measure the effective temperature of each of the single solutions in the reaction chambers of the biochip and to provide feedback to the TCE to heat or cool the solution to set or maintain the solution at a desired temperature;
simultaneously amplifying said plurality of loci by using the at least one thermosensor, the controller and the TCE to sequentially thermally cycle the temperature of the nucleic acid solution in each reaction chamber between a denaturing state, an annealing state, and an extension state for a predetermined number of cycles at heating and cooling rates of about 4-1 50° C./sec, and minimizing the transition times between the extension, denaturation, and annealing states to yield 5 or more amplified loci in each reaction chamber in 97 minutes or less.
4. The method of claim 1 or 3 wherein the biochip is plastic.
5. The method of claim 1 or 3 , wherein the amplified loci are produced in less than 45 minutes.
6. The method of claim 3 further comprising, prior to the sequential thermal cycling,
heating the one or a plurality of reaction solutions to a first temperature suitable for hot-start activation of the nucleic acid polymerases; and
holding the one or a plurality of reaction solutions at the first temperature for a first period of time suitable for hot-start activation of the nucleic acid polymerases.
7. The method of claim 6 , wherein the first period of time is less than 90 seconds.
8. The method of claim 6 wherein the first temperature is about 90 to about 99° C.
9. The method claim 5 , wherein the nucleic acid polymerase has an extension rate of at least 100 bp/sec.
10. The method of claim 5 , wherein each reaction chamber has a volume of less than 100 μL.
11. The method of claim 5 , wherein each reaction chamber is separated from a thermal cycler by less than 200 μm.
12. The method of claim 5 , wherein each nucleic acid solution comprises about 1 to about 1000 copies of a target nucleic acid.
13. The method claim 5 , wherein the nucleic acid polymerase is SpeedSTAR, PHUSION, Hot MasterTaq™, PHUSION Mpx, PyroStart, KOD, Z-Taq, or CS3AC/LA.
14. The method of claim 5 , wherein analysis of each of the amplified nucleic acid products satisfies forensic interpretation guidelines.
15. The method of claim 5 , wherein the denaturing state is about 95° C. for about 4 seconds.
16. The method of claim 5 , wherein the annealing state is about 59° C. for about 15 seconds.
17. The method of claim 5 , wherein the extension state is about 72° C. for about 7 seconds.
18. The method claim 5 , wherein the final state is about 70° C. for about 90 seconds.
19. The method claim 5 , wherein the one or a plurality of reaction solutions are cooled from the denaturing state to the annealing state at a first cooling rate of about 10 to about 50° C./sec.
20. The method of claim 5 , wherein the one or a plurality of reaction solutions are heated from the annealing state to the extension state at a first heating rate of about 10 to about 50° C./sec.
21. The method claim 5 , wherein the one or a plurality of reaction solutions are heated from the extension state to the denaturing state at a second heating rate of about 10 to about 50° C./sec.
22. The method of claim 5 , wherein the one or a plurality of amplified nucleic acid products are obtained in about 10 to about 90 minutes.
23. The method of claim 5 , wherein each reaction solution comprises about 0.005 to about 10 ng of a target nucleic acid.
24. The method of claim 5 , wherein the target nucleic acid comprises a human nucleic acid, microbial nucleic acid, or viral nucleic acid.
25. The method of claim 5 , wherein 10 to 250 loci are simultaneously amplified.
26. The method of claim 5 , wherein the loci comprise amelogenin, D8S 1179, D21S11, D7S820, CFS1PO, D3S1358, TH01, D13S317, D16S539, D2S1338, D19S433, vWA, TPDX, D18S51, D5S818, FGA, or a plurality thereof.
27. The method of claim 5 , wherein the predetermined number of cycles is between about 10 and about 50 cycles.
28. The method of claim 5 , wherein one or a plurality of thin-wall reaction tubes comprise the one or a plurality of reaction chambers.